Third Quarter 2026 Financial Highlights
- Total economic return of
$(1.48) per common share, or (11.5)% of beginning book value - Book value per common share of
$10.91 as ofSeptember 30, 2026 , a decrease of$(1.99) from$12.90 as ofJune 30, 2026 - Comprehensive loss of
$(1.49) per common share and net loss of$(1.34) per common share - Dividends declared of
$0.51 per common share - Liquidity of
$1.3 billion of cash and unpledged securities, representing 42% of total equity, as ofSeptember 30, 2026 - Leverage including to-be-announced ("TBA") securities at cost was 9.0 times shareholders' equity as of
September 30, 2026 , compared to 8.1 times shareholders' equity as ofJune 30, 2026
Third Quarter 2026 Portfolio and Capital Highlights
- Total investment portfolio of
$28.3 billion , an increase of 3% relative toJune 30, 2026 driven by$3.2 billion of MBS purchases:- Agency RMBS portfolio, including TBAs, increased approximately 3% to
$26.8 billion - Agency CMBS portfolio increased approximately 3% to
$1.4 billion - 99.99% of investment portfolio is in highly liquid Agency securities
- Agency RMBS represents 95% of total portfolio; Agency CMBS represents 5% of total portfolio
- Agency RMBS portfolio, including TBAs, increased approximately 3% to
- Raised
$384 million of capital, net of commissions, during the quarter, including$268 million of common equity through the Company's at-the-market ("ATM") program and$116 million through the issuance of 9.375% Series D fixed-rate cumulative redeemable preferred stock
Management Remarks
“We believe today’s Agency mortgage market presents a compelling forward investment opportunity,” said
Earnings Conference Call
As previously announced, the Company's conference call to discuss these results is today at
Summary of Third Quarter 2026 Results
Total economic return for the third quarter of 2026 reflected a decline in book value per common share to
The Company grew its capital base by
Interest income increased from the prior quarter, driven by the Company's continued capital deployment into Agency MBS. The average balance of interest-earning assets grew 10% during the third quarter of 2026. Operating expenses decreased by
The following tables summarize the changes in the Company's financial position during the third quarter of 2026:
($s in thousands) |
| Net Changes in Fair Value |
| Components of Comprehensive Income |
| Common Equity Rollforward | ||||||
Balance as of |
|
|
|
|
| $ | 3,063,567 |
| ||||
Net interest income |
|
|
| $ | 101,562 |
|
|
| ||||
Net periodic interest from interest rate swaps |
|
|
|
| 82 |
|
|
| ||||
Operating expenses |
|
|
|
| (12,594 | ) |
|
| ||||
Preferred stock dividends |
|
|
|
| (2,769 | ) |
|
| ||||
Changes in fair value: |
|
|
|
|
|
| ||||||
MBS and other |
| $ | (1,502,120 | ) |
|
|
|
| ||||
TBAs |
|
| (124,902 | ) |
|
|
|
| ||||
|
| 377,310 |
|
|
|
|
| |||||
Options on |
|
| 743 |
|
|
|
|
| ||||
Interest rate swaps |
|
| 790,435 |
|
|
|
|
| ||||
Interest rate swaptions |
|
| (2,581 | ) |
|
|
|
| ||||
Total net change in fair value |
|
|
|
| (461,115 | ) |
|
| ||||
Comprehensive loss to common shareholders |
|
|
|
|
|
| (374,834 | ) | ||||
Capital transactions: |
|
|
|
|
|
| ||||||
Net proceeds from stock issuance (2) |
|
|
|
|
|
| 260,984 |
| ||||
Common dividends declared |
|
|
|
|
|
| (129,162 | ) | ||||
Balance as of |
|
|
|
|
| $ | 2,820,555 |
| ||||
(1) | Amount represents total shareholders' equity less the aggregate liquidation preference of the Company's Series C preferred stock of | |
(2) | Amount includes net proceeds of approximately | |
(3) | Amount represents total shareholders' equity less the aggregate liquidation preference of the Company's Series C and Series D preferred stocks of |
Investment Portfolio and Financing
The following table provides detail on the Company's MBS investments, including TBA securities, as of the periods indicated:
|
|
| ||||||||||||||||||||||||
($ in thousands) |
| Amortized Cost/Implied Cost Basis |
| Unrealized Gain (Loss) |
|
Fair Value | % of Portfolio |
| Amortized Cost/Implied Cost Basis |
| Unrealized Gain (Loss) |
| Fair Value | % of Portfolio | ||||||||||||
Fixed rate Agency RMBS: |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||
2.0% coupon |
| $ | 1,439,531 |
| $ | (213,063 | ) |
| $ | 1,226,468 | 4 | % |
| $ | 1,467,013 |
| $ | (125,450 | ) |
| $ | 1,341,563 | 5 | % | ||
2.5% coupon |
|
| 801,131 |
|
| (136,745 | ) |
|
| 664,386 | 2 | % |
|
| 728,917 |
|
| (91,725 | ) |
|
| 637,192 | 2 | % | ||
4.0% coupon |
|
| 1,483,955 |
|
| (92,278 | ) |
|
| 1,391,677 | 5 | % |
|
| 1,065,039 |
|
| (7,546 | ) |
|
| 1,057,493 | 4 | % | ||
4.5% coupon (1) |
|
| 2,426,164 |
|
| (153,056 | ) |
|
| 2,273,108 | 8 | % |
|
| 2,147,675 |
|
| (1,055 | ) |
|
| 2,146,620 | 8 | % | ||
5.0% coupon |
|
| 7,973,568 |
|
| (504,783 | ) |
|
| 7,468,785 | 26 | % |
|
| 7,969,870 |
|
| (27,255 | ) |
|
| 7,942,615 | 29 | % | ||
5.5% coupon |
|
| 10,162,745 |
|
| (515,698 | ) |
|
| 9,647,047 | 34 | % |
|
| 9,028,071 |
|
| (545 | ) |
|
| 9,027,526 | 33 | % | ||
6.0% coupon |
|
| 1,812,455 |
|
| (69,451 | ) |
|
| 1,743,004 | 6 | % |
|
| 1,459,407 |
|
| 1,280 |
|
|
| 1,460,687 | 5 | % | ||
TBA 4.0% |
|
| 5,386 |
|
| (162 | ) |
|
| 5,224 | — | % |
|
| 11,259 |
|
| (28 | ) |
|
| 11,231 | — | % | ||
TBA 4.5% (2) |
|
| 225,881 |
|
| (9,715 | ) |
|
| 216,166 | 1 | % |
|
| 1,039,010 |
|
| 5,571 |
|
|
| 1,044,581 | 4 | % | ||
TBA 5.0% |
|
| 1,021,997 |
|
| (29,966 | ) |
|
| 992,031 | 4 | % |
|
| 856,769 |
|
| 2,181 |
|
|
| 858,950 | 3 | % | ||
TBA 5.5% |
|
| 508,784 |
|
| (18,086 | ) |
|
| 490,698 | 2 | % |
|
| 602,276 |
|
| 255 |
|
|
| 602,531 | 2 | % | ||
TBA 6.0% |
|
| 733,328 |
|
| (20,172 | ) |
|
| 713,156 | 3 | % |
|
| — |
|
| — |
|
|
| — | — | % | ||
Total Agency RMBS |
| $ | 28,594,925 |
| $ | (1,763,175 | ) |
| $ | 26,831,750 | 95 | % |
| $ | 26,375,306 |
| $ | (244,317 | ) |
| $ | 26,130,989 | 95 | % | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||
Agency CMBS/CMBS IO (3) |
| $ | 1,577,545 |
| $ | (79,414 | ) |
| $ | 1,498,131 | 5 | % |
| $ | 1,463,111 |
| $ | (10,610 | ) |
| $ | 1,452,501 | 5 | % | ||
Total |
| $ | 30,172,470 |
| $ | (1,842,589 | ) |
| $ | 28,329,881 | 100 | % |
| $ | 27,838,417 |
| $ | (254,927 | ) |
| $ | 27,583,490 | 100 | % | ||
(1) Includes a par value of | ||||||||||||||||||||||||||
(2) Includes a notional amount of | ||||||||||||||||||||||||||
(3) CMBS IO ("Interest only") includes Agency and non-Agency issued securities. The amortized cost and fair value of the Company's CMBS IO represent less than 0.1% of its total investment portfolio as of the dates presented. | ||||||||||||||||||||||||||
The following table provides detail on the Company's repurchase agreement borrowings outstanding as of the dates indicated:
|
|
| ||||||||||||||
Remaining Term to Maturity |
| Balance |
| Weighted Average Rate |
| WAVG Original Term to Maturity |
| Balance |
| Weighted Average Rate |
| WAVG Original Term to Maturity | ||||
($s in thousands) |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Less than 30 days |
| $ | 10,662,438 |
| 3.88 | % |
| 79 |
| $ | 9,949,865 |
| 3.78 | % |
| 76 |
30 to 90 days |
|
| 12,563,547 |
| 3.93 | % |
| 88 |
|
| 9,852,555 |
| 3.78 | % |
| 91 |
91 to 180 days |
|
| 964,291 |
| 4.00 | % |
| 179 |
|
| 2,842,322 |
| 3.79 | % |
| 181 |
Total |
| $ | 24,190,276 |
| 3.91 | % |
| 87 |
| $ | 22,644,742 |
| 3.79 | % |
| 96 |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
The following table provides details on the performance of the Company's MBS, net of financing for the third quarter of 2026 compared to the prior quarter:
| Three Months Ended | |||||||||||||||||||
|
| |||||||||||||||||||
($s in thousands) | Interest Income/Expense |
| Average Balance (1)(2) |
| Effective Yield/ Financing Cost(3)(4) |
| Interest Income/Expense |
| Average Balance (1)(2) |
| Effective Yield/ Financing Cost(3)(4) | |||||||||
Agency RMBS | $ | 311,244 |
|
| $ | 24,761,556 |
| 5.03 | % |
| $ | 280,970 |
|
| $ | 22,581,412 |
| 4.98 | % | |
Agency CMBS/CMBS IO(5) |
| 16,958 |
|
|
| 1,456,850 |
| 4.55 | % |
|
| 15,270 |
|
|
| 1,333,481 |
| 4.52 | % | |
Other investments |
| 5 |
|
|
| 431 |
| 3.71 | % |
|
| 6 |
|
|
| 445 |
| 3.89 | % | |
Subtotal |
| 328,207 |
|
|
| 26,218,837 |
| 5.00 | % |
|
| 296,246 |
|
|
| 23,915,338 |
| 4.95 | % | |
Cash equivalents |
| 4,290 |
|
|
|
|
|
|
| 6,505 |
|
|
|
|
| |||||
Total interest income | $ | 332,497 |
|
|
|
|
|
| $ | 302,751 |
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||
Repurchase agreement financing |
| (230,935 | ) |
|
| 23,626,939 |
| (3.82 | )% |
|
| (208,968 | ) |
|
| 21,803,737 |
| (3.79 | )% | |
Net interest income/net interest spread | $ | 101,562 |
|
|
|
| 1.18 | % |
| $ | 93,783 |
|
|
|
| 1.16 | % | |||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||
Net periodic interest from interest rate swaps |
| 82 |
|
|
|
| — | % |
|
| 542 |
|
|
|
| 0.01 | % | |||
Economic net interest income (6) | $ | 101,644 |
|
|
|
| 1.18 | % |
| $ | 94,325 |
|
|
|
| 1.17 | % | |||
(1) | Average balance for assets is calculated as a simple average of the daily amortized cost and excludes securities pending settlement if applicable. | |
(2) | Average balance for liabilities is calculated as a simple average of the daily repurchase agreement borrowings outstanding during the period. | |
(3) | Effective yield is calculated by dividing annualized interest income by the average balance of asset type outstanding during the reporting period. Unscheduled adjustments to premium/discount amortization/accretion, such as for prepayment compensation, are not annualized in this calculation. | |
(4) | Financing cost is calculated by dividing annualized interest expense by the total average balance of borrowings outstanding during the period with an assumption of 360 days in a year. | |
(5) | CMBS IO ("Interest only") includes Agency and non-Agency issued securities. The amortized cost and fair value of the Company's CMBS IO represent less than 0.1% of its investment portfolio and interest income from CMBS IO comprised less than 1% of the Company's interest income for the periods presented. | |
(6) | Represents a non-GAAP measure. See "Non-GAAP Financial Measures" below for a reconciliation to the most comparable GAAP financial measure. |
Hedging Portfolio
The following tables provide details on the Company's interest rate hedging portfolio as of the dates indicated:
|
|
| ||||||||||
Derivative Type - Short Positions |
| Notional Amount |
| WAVG Fixed Pay Rate |
| Notional Amount |
| WAVG Fixed Pay Rate | ||||
($s in thousands) |
|
|
|
|
|
|
|
| ||||
1-3 year pay-fixed interest rate swaps |
| $ | 1,925,000 |
|
| 3.63% |
| $ | — |
|
| —% |
3-5 year pay-fixed interest rate swaps |
|
| 4,080,000 |
|
| 3.63% |
|
| 4,375,000 |
|
| 3.45% |
5-7 year pay-fixed interest rate swaps |
|
| 4,820,000 |
|
| 3.85% |
|
| 4,060,000 |
|
| 3.65% |
7-10 year pay-fixed interest rate swaps |
|
| 5,845,000 |
|
| 3.93% |
|
| 5,065,000 |
|
| 3.86% |
10-15 year pay-fixed interest rate swaps |
|
| 142,000 |
|
| 4.79% |
|
| — |
|
| —% |
15-20 year pay-fixed interest rate swaps |
|
| 785,000 |
|
| 4.39% |
|
| 590,000 |
|
| 4.40% |
|
| $ | 17,597,000 |
|
| 3.83% |
| $ | 14,090,000 |
|
| 3.70% |
|
|
|
|
|
|
|
|
| ||||
5-year |
| $ | (650,000 | ) |
| n/a |
| $ | (750,000 | ) |
| n/a |
10-year |
|
| (2,893,700 | ) |
| n/a |
|
| (2,516,500 | ) |
| n/a |
30-year |
|
| (3,132,800 | ) |
| n/a |
|
| (991,800 | ) |
| n/a |
|
| $ | (6,676,500 | ) |
|
|
| $ | (4,258,300 | ) |
|
|
|
|
| ||||||||
Derivative Type - Long Positions |
| Notional Amount |
| Average Fixed Receive Rate |
| Notional Amount |
| Average Fixed Receive Rate | ||
($s in thousands) |
|
|
|
|
|
|
|
| ||
Interest rate swaptions |
| $ | 750,000 |
| 3.25% |
| $ | 750,000 |
| 3.25% |
The following table provides detail on the performance of the Company's derivative instruments during the periods indicated:
|
|
|
| Three Months Ended | ||||||
Type of Derivative Instrument |
| Purpose |
|
| ||||||
|
|
|
| ($s in thousands) | ||||||
Unrealized gains (losses): |
|
|
|
|
|
| ||||
TBA securities |
| Investment |
| $ | (86,079 | ) |
| $ | 17,024 |
|
| Interest rate hedge |
|
| 278,275 |
|
|
| (96,155 | ) | |
Options on |
| Interest rate hedge |
|
| — |
|
|
| — |
|
Interest rate swaps |
| Interest rate hedge |
|
| 782,825 |
|
|
| 135,175 |
|
Interest rate swaptions |
| Interest rate hedge |
|
| (2,581 | ) |
|
| (4,275 | ) |
Total net unrealized gains |
|
|
|
| 972,440 |
|
|
| 51,769 |
|
|
|
|
|
|
|
| ||||
Realized gains (losses) upon settlement, maturity or termination: |
|
|
|
|
|
| ||||
TBA securities |
| Investment |
|
| (38,823 | ) |
|
| (36,253 | ) |
| Interest rate hedge |
|
| 99,035 |
|
|
| 112,723 |
| |
Options on |
| Interest rate hedge |
|
| 743 |
|
|
| — |
|
Interest rate swaps |
| Interest rate hedge |
|
| 7,610 |
|
|
| 64 |
|
Total net realized gains |
|
|
|
| 68,565 |
|
|
| 76,534 |
|
|
|
|
|
|
|
| ||||
Net periodic interest from interest rate swaps |
| Interest rate hedge |
|
| 82 |
|
|
| 542 |
|
Gain on derivative instruments, net |
|
|
| $ | 1,041,087 |
|
| $ | 128,845 |
|
|
|
|
|
|
|
| ||||
The Company typically designates certain of its interest rate derivatives as hedges for tax purposes. Gains and losses realized upon maturity or termination of derivatives designated as hedges for tax purposes are amortized into the Company's REIT taxable income over the original periods hedged by those derivatives. These hedge gains are not included in the Company's current or future earnings available for distribution ("EAD"), a non-GAAP measure, but will be part of the Company's future distribution requirements. The table below provides the projected amortization of the Company's net deferred tax hedge gains that may be recognized as taxable income over the periods indicated, given conditions known as of
Projected Period of Recognition for Tax Hedge Gains, Net |
| ||
|
| ($ in thousands) | |
Fiscal year 2026 |
| $ | 97,989 |
Fiscal year 2027 |
|
| 96,449 |
Fiscal year 2028 |
|
| 90,414 |
Fiscal year 2029 |
|
| 91,733 |
Fiscal year 2030 and thereafter |
|
| 249,014 |
|
| $ | 625,599 |
|
|
| |
Third Quarter 2026 Preliminary Financial Statements and Other Supplemental Information
Consolidated Balance Sheets | ||||||||||||
($s in thousands except per share data) |
|
| ||||||||||
ASSETS | (unaudited) |
| (unaudited) |
| (audited) | |||||||
Cash and cash equivalents | $ | 993,008 |
|
| $ | 607,562 |
|
| $ | 531,043 |
| |
Cash collateral posted to counterparties |
| 834,736 |
|
|
| 570,020 |
|
|
| 399,344 |
| |
Mortgage-backed securities (including pledged of |
| 25,912,607 |
|
|
| 25,066,198 |
|
|
| 16,306,988 |
| |
Due from counterparties |
| 61,439 |
|
|
| 53,446 |
|
|
| 17,425 |
| |
Derivative assets |
| — |
|
|
| 8,441 |
|
|
| 10,498 |
| |
Accrued interest receivable |
| 113,913 |
|
|
| 104,272 |
|
|
| 67,940 |
| |
Other assets, net |
| 9,503 |
|
|
| 9,663 |
|
|
| 8,940 |
| |
Total assets | $ | 27,925,206 |
|
| $ | 26,419,602 |
|
| $ | 17,342,178 |
| |
|
|
|
|
|
| |||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
| |||||||
Liabilities: |
|
|
|
|
| |||||||
Repurchase agreements | $ | 24,190,276 |
|
| $ | 22,644,742 |
|
| $ | 13,904,231 |
| |
Due to counterparties |
| 389,511 |
|
|
| 380,947 |
|
|
| 811,656 |
| |
Derivative liabilities |
| 89,336 |
|
|
| 9,117 |
|
|
| 4,830 |
| |
Cash collateral posted by counterparties |
| — |
|
|
| 15,500 |
|
|
| 8,373 |
| |
Accrued interest payable |
| 137,153 |
|
|
| 135,194 |
|
|
| 95,196 |
| |
Accrued dividends payable |
| 50,580 |
|
|
| 46,943 |
|
|
| 37,171 |
| |
Other liabilities |
| 16,295 |
|
|
| 12,092 |
|
|
| 18,577 |
| |
Total liabilities |
| 24,873,151 |
|
|
| 23,244,535 |
|
|
| 14,880,034 |
| |
|
|
|
|
|
| |||||||
Shareholders’ equity: |
|
|
|
|
| |||||||
Preferred stock | $ | 223,593 |
|
| $ | 107,843 |
|
| $ | 107,843 |
| |
Common stock |
| 2,584 |
|
|
| 2,374 |
|
|
| 1,748 |
| |
Additional paid-in capital |
| 4,025,147 |
|
|
| 3,760,123 |
|
|
| 2,921,551 |
| |
Accumulated other comprehensive loss |
| (164,603 | ) |
|
| (128,074 | ) |
|
| (127,061 | ) | |
Accumulated deficit |
| (1,034,666 | ) |
|
| (567,199 | ) |
|
| (441,937 | ) | |
Total shareholders' equity |
| 3,052,055 |
|
|
| 3,175,067 |
|
|
| 2,462,144 |
| |
Total liabilities and shareholders’ equity | $ | 27,925,206 |
|
| $ | 26,419,602 |
|
| $ | 17,342,178 |
| |
|
|
|
|
|
| |||||||
Preferred stock aggregate liquidation preference | $ | 231,500 |
|
| $ | 111,500 |
|
| $ | 111,500 |
| |
Book value per common share | $ | 10.91 |
|
| $ | 12.90 |
|
| $ | 13.45 |
| |
Common shares outstanding | 258,430,745 |
|
| 237,414,259 | 174,814,912 | |||||||
Consolidated Statements of Comprehensive Income (Loss) | ||||||||||||
|
|
| ||||||||||
| Three Months Ended |
| Nine Months Ended | |||||||||
($s in thousands except per share data) |
|
| ||||||||||
| (unaudited) |
| (unaudited) |
| (unaudited) | |||||||
INTEREST INCOME |
|
|
|
|
| |||||||
Interest income | $ | 332,497 |
|
| $ | 302,751 |
|
| $ | 892,637 |
| |
Interest expense |
| (230,935 | ) |
|
| (208,968 | ) |
|
| (618,039 | ) | |
Net interest income |
| 101,562 |
|
|
| 93,783 |
|
|
| 274,598 |
| |
|
|
|
|
|
| |||||||
GAINS (LOSSES) |
|
|
|
|
| |||||||
Realized (loss) gain on sales of investments, net |
| (544 | ) |
|
| — |
|
|
| 8,177 |
| |
Unrealized loss on investments, net |
| (1,465,047 | ) |
|
| (25,622 | ) |
|
| (1,742,480 | ) | |
Gain on derivative instruments, net |
| 1,041,087 |
|
|
| 128,845 |
|
|
| 1,274,659 |
| |
Total (losses) gains, net |
| (424,504 | ) |
|
| 103,223 |
|
|
| (459,644 | ) | |
|
|
|
|
|
| |||||||
EXPENSES |
|
|
|
|
| |||||||
General and administrative expenses |
| (11,062 | ) |
|
| (15,206 | ) |
|
| (46,745 | ) | |
Other operating expense, net |
| (1,532 | ) |
|
| (1,007 | ) |
|
| (3,315 | ) | |
Total operating expenses |
| (12,594 | ) |
|
| (16,213 | ) |
|
| (50,060 | ) | |
|
|
|
|
|
| |||||||
Net (loss) income |
| (335,536 | ) |
|
| 180,793 |
|
|
| (235,106 | ) | |
Preferred stock dividends |
| (2,769 | ) |
|
| (2,650 | ) |
|
| (8,076 | ) | |
Net (loss) income to common shareholders | $ | (338,305 | ) |
| $ | 178,143 |
|
| $ | (243,182 | ) | |
|
|
|
|
|
| |||||||
Unrealized loss on available-for-sale investments, net |
| (36,529 | ) |
|
| (865 | ) |
|
| (37,542 | ) | |
Total other comprehensive loss |
| (36,529 | ) |
|
| (865 | ) |
|
| (37,542 | ) | |
Comprehensive (loss) income to common shareholders | $ | (374,834 | ) |
| $ | 177,278 |
|
| $ | (280,724 | ) | |
|
|
|
|
|
| |||||||
Weighted average common shares-basic |
| 251,842,414 |
|
|
| 222,220,145 |
|
|
| 224,905,226 |
| |
Weighted average common shares-diluted |
| 251,842,414 |
|
|
| 223,603,596 |
|
|
| 224,905,226 |
| |
Net (loss) income per common share-basic | $ | (1.34 | ) |
| $ | 0.80 |
|
| $ | (1.08 | ) | |
Net (loss) income per common share-diluted | $ | (1.34 | ) |
| $ | 0.80 |
|
| $ | (1.08 | ) | |
Dividends declared per common share | $ | 0.51 |
|
| $ | 0.51 |
|
| $ | 1.53 |
| |
Non-GAAP Financial Measures
In addition to reporting the Company’s financial results determined in accordance with GAAP, management of the Company believes that investors’ understanding of our operating results may be enhanced by the use of non-GAAP financial measures, which are used by management internally, along with GAAP measures, to evaluate our performance. Our non-GAAP financial measures include earnings available for distribution (“EAD”) to common shareholders (including per common share) and economic net interest income and the related metric economic net interest spread. Management believes these non-GAAP financial measures may be useful to investors because they are viewed by management as additional measures of the investment portfolio’s return.
Drop income generated by TBA dollar roll positions, which is included in "gain (loss) on derivatives instruments, net" on the Company's consolidated statements of comprehensive income, is included in EAD because management views drop income as the economic equivalent of net interest income (interest income less implied financing cost) on the underlying Agency security from trade date to settlement date. However, drop income does not represent the total realized gain/loss from the Company’s investments in TBA securities.
Management also includes net periodic interest from its interest rate swaps, which is included in "gain (loss) on derivatives instruments, net," in EAD and economic net interest income because interest rate swaps are used by the Company to economically hedge the impact of changing interest rates on its borrowing costs from repurchase agreements, and including net periodic interest from interest rate swaps is a helpful indicator of the Company’s total financing cost in addition to GAAP interest expense.
Non-GAAP financial measures are not a substitute for GAAP measures and may be different from non-GAAP measures used by other companies. In addition, other companies, including in our industry, may calculate comparable measures differently, which reduces their usefulness as comparative measures. Investors should not rely on any single financial measure when evaluating our business. These non-GAAP measures should be considered as supplemental in nature and not as a substitute for our operating results in accordance with GAAP.
Reconciliations of each non-GAAP measure to certain GAAP financial measures are provided below.
| Three Months Ended | |||||||
($s in thousands except per share data) |
| |||||||
Comprehensive income (loss) to common shareholders (GAAP) | $ | (374,834 | ) |
| $ | 177,278 |
| |
Less: |
|
|
| |||||
Change in fair value of investments, net (1) |
| 1,502,120 |
|
|
| 26,487 |
| |
Change in fair value of derivative instruments, net (2) |
| (1,032,611 | ) |
|
| (123,082 | ) | |
EAD to common shareholders (non-GAAP) | $ | 94,675 |
|
| $ | 80,683 |
| |
|
|
|
| |||||
Weighted average common shares |
| 251,842,414 |
|
|
| 222,220,145 |
| |
EAD per common share (non-GAAP) | $ | 0.38 |
|
| $ | 0.36 |
| |
|
|
|
| |||||
Net interest income (GAAP) | $ | 101,562 |
|
| $ | 93,783 |
| |
Net periodic interest from interest rate swaps |
| 82 |
|
|
| 542 |
| |
Economic net interest income |
| 101,644 |
|
|
| 94,325 |
| |
TBA drop income (3) |
| 8,394 |
|
|
| 5,221 |
| |
Operating expenses |
| (12,594 | ) |
|
| (16,213 | ) | |
Preferred stock dividends |
| (2,769 | ) |
|
| (2,650 | ) | |
EAD to common shareholders (non-GAAP) | $ | 94,675 |
|
| $ | 80,683 |
| |
|
|
|
| |||||
Net interest spread (GAAP) |
| 1.18 | % |
|
| 1.16 | % | |
Net periodic interest as a percentage of average repurchase borrowings |
| — | % |
|
| 0.01 | % | |
Economic net interest spread (non-GAAP) |
| 1.18 | % |
|
| 1.17 | % | |
|
|
|
| |||||
(1) | Amounts include realized and unrealized gains and losses from the Company's MBS. | |
(2) | Amounts include unrealized gains and losses from changes in fair value of derivatives, including TBAs accounted for as derivative instruments, and realized gains and losses on terminated derivatives. Amounts exclude TBA drop income and net periodic interest from interest rate swaps. | |
(3) | TBA drop income is calculated by multiplying the notional amount of the TBA dollar roll positions by the difference in price between two TBA securities with the same terms but different settlement dates. |
Forward Looking Statements
This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “expect,” “forecast,” “anticipate,” “estimate,” “project,” “plan,” "may," "could," "will," "continue" and similar expressions identify forward-looking statements that are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements in this release, including statements made in
All forward-looking statements are qualified in their entirety by these and other cautionary statements that the Company makes from time to time in its filings with the Securities and Exchange Commission and other public communications. The Company cannot assure the reader that it will realize the results or developments the Company anticipates or, even if substantially realized, that they will result in the consequences or affect the Company or its operations in the way the Company expects. As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements included herein or that may be made elsewhere from time to time by, or on behalf of, the Company. Forward-looking statements speak only as of the date made. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances arising after the date on which they were made, except as otherwise required by law.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20261019160083/en/
Investor Relations Contact
Email: askdx@dynexcapital.com
Phone Number: 804-217-5897
Source: